AlzeCure Pharma AB Registered Shs News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.11.20	AlzeCure publishes its interim report for January - September 2020 (PR Newswire)
17.11.20	AlzeCure publishes its interim report for January - September 2020 (PR Newswire)
12.11.20	AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer's disease (PR Newswire)
12.11.20	AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer's disease (PR Newswire)
11.11.20	Poster presentation with the Alzstatin platform now available on AlzeCure's website (PR Newswire)
11.11.20	Poster presentation with ACD856 in Alzheimer's now available on AlzeCure's website (PR Newswire)
11.11.20	Poster presentation with the Alzstatin platform now available on AlzeCure's website (PR Newswire)
11.11.20	Poster presentation with ACD856 in Alzheimer's now available on AlzeCure's website (PR Newswire)
08.10.20	AlzeCure gets abstract on the Alzstatin platform against Alzheimer's accepted for poster presentation at CTAD (PR Newswire)
08.10.20	AlzeCure gets abstract on the Alzstatin platform against Alzheimer's accepted for poster presentation at CTAD (PR Newswire)
28.09.20	AlzeCure Pharma provides a scientific update on Alzheimer's disease and the Alzstatin project platform (PR Newswire)
25.08.20	AlzeCure publishes its interim report for January - June 2020 (PR Newswire)
25.08.20	AlzeCure publishes its interim report for January - June 2020 (PR Newswire)
04.06.20	AlzeCure Announces Positive Data From Clinical Study with ACD856 (PR Newswire)
04.06.20	AlzeCure Announces Positive Data From Clinical Study with ACD856 (PR Newswire)
20.05.20	Report From the Annual General Meeting of AlzeCure Pharma on 20 May 2020 (PR Newswire)
20.05.20	Report From the Annual General Meeting of AlzeCure Pharma on 20 May 2020 (PR Newswire)
14.05.20	Doctoral Thesis in Alzheimer's Awarded Best Thesis 2019 at Sahlgrenska Academy (PR Newswire)
14.05.20	Doctoral Thesis in Alzheimer's Awarded Best Thesis 2019 at Sahlgrenska Academy (PR Newswire)
05.05.20	AlzeCure Publishes its Interim Report for Q1 2020 (PR Newswire)
05.05.20	AlzeCure Publishes its Interim Report for Q1 2020 (PR Newswire)
30.04.20	A New Doctoral Thesis in Alzheimer's Presented Today by AlzeCure Pharma and Karolinska Institutet (PR Newswire)
30.04.20	A New Doctoral Thesis in Alzheimer's Presented Today by AlzeCure Pharma and Karolinska Institutet (PR Newswire)
15.04.20	AlzeCure Pharma Publishes its Annual Report for 2019 (PR Newswire)
15.04.20	AlzeCure Pharma Publishes its Annual Report for 2019 (PR Newswire)
02.04.20	AlzeCure Pharma Today Presented Key Preclinical Data on its Novel Cognitive Enhancer at the AAT-AD/PD Conference (PR Newswire)
02.04.20	AlzeCure Pharma Today Presented Key Preclinical Data on its Novel Cognitive Enhancer at the AAT-AD/PD Conference (PR Newswire)
16.03.20	AlzeCure Pharma to Present Late Breaking Abstract at the AAT-AD/PD Conference (Advances in Alzheimer's and Parkinson's Therapies) (PR Newswire)
16.03.20	AlzeCure Pharma to Present Late Breaking Abstract at the AAT-AD/PD Conference (Advances in Alzheimer's and Parkinson's Therapies) (PR Newswire)
08.01.20	Martin Jönsson Appointed New CEO of AlzeCure Pharma (PR Newswire)
08.01.20	Martin Jönsson Appointed New CEO of AlzeCure Pharma (PR Newswire)
07.01.20	AlzeCure Pharma Conducts Strategic Inlicensing of Clinical Phase Drug Candidate for Neuropathic Pain (PR Newswire)
07.01.20	AlzeCure Pharma Conducts Strategic Inlicensing of Clinical Phase Drug Candidate for Neuropathic Pain (PR Newswire)
20.12.19	AlzeCure Initiates Clinical Trial With ACD856 (PR Newswire)
20.12.19	AlzeCure Initiates Clinical Trial With ACD856 (PR Newswire)
22.08.19	AlzeCure Publishes its Interim Report for January - June 2019 (PR Newswire)
22.08.19	AlzeCure Publishes its Interim Report for January - June 2019 (PR Newswire)
22.05.19	Report from the Annual General Meeting of AlzeCure Pharma on 22 May 2019 (PR Newswire)
22.05.19	Report from the Annual General Meeting of AlzeCure Pharma on 22 May 2019 (PR Newswire)
15.04.19	AlzeCure Publishes its Annual Report for 2018 (PR Newswire)
15.04.19	AlzeCure Publishes its Annual Report for 2018 (PR Newswire)
25.03.19	AlzeCure to Present at International Scientific Conference (PR Newswire)
25.03.19	AlzeCure to Present at International Scientific Conference (PR Newswire)
20.03.19	AlzeCure Initiates New Drug Project Within Pain (PR Newswire)
20.03.19	AlzeCure Initiates New Drug Project Within Pain (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sonova Hldg	262.10	3.39 %	K V
Lonza Grp	584.80	2.38 %	K V
Logitech Intl	66.76	1.71 %	K V
Part Grp Hldg	1’114.00	1.41 %	K V
Swisscom	544.00	0.74 %	K V
ABB	45.07	0.04 %	K V
Novartis	90.91	-0.22 %	K V
Zurich Insur Gr	581.00	-0.34 %	K V
Roche Hldg G	257.60	-0.88 %	K V
Kuehne+Nagel Int	177.85	-3.24 %	K V

AlzeCure Pharma AB Registered Shs Aktie VALOR 37512484 / ISIN SE0010133785

Nachrichten zu AlzeCure Pharma AB Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten